tiprankstipranks
pc:latig

Latigo Biotherapeutics

Thousand Oaks, CA, US
https://www.latigobio.com/
Latigo Biotherapeutics is a clinical-stage biotechnology company focused on developing innovative non-opioid pain treatments. The company specializes in creating highly selective Nav1.8 inhibitors, which target pain at its source, aiming to provide effective pain management solutions without the use of opioids.

Leadership & Board

Current Number of Employees56
Current LinkedIn Followers9,043

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$150M
Total Amount Raised$150M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$150M
Latest Funding Amount$150M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

Latigo Biotherapeutics had 56 employees as of May 18, 2026. The number of employees increased by 0 (0.00%) week-over-week.
56Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Latigo Biotherapeutics had 9,043 followers as of May 18, 2026. The number of followers increased by 29 (0.32%) week-over-week.
9,043Latest Followers Count
29(0.32%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 17, 2025
Series B
$150.00M

Investors

Investor Name
Funding Round

Related News and Analysis